Modern possibilities of antiepileptic therapy at the start of treatment of focal epilepsy
The report presents data on the evaluation of efficacy and tolerability, as well as the dynamics of epileptiform activity index in adolescents and adults with newly diagnosed focal epilepsy during lacosamide therapy.
Saved in:
Main Author: | P. N. Vlasov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2021-07-01
|
Series: | Эпилепсия и пароксизмальные состояния |
Subjects: | |
Online Access: | https://www.epilepsia.su/jour/article/view/685 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epileptiform activity index for assessing oxcarbazepin therapy of newly-diagnosed focal epilepsy in adolescents and adults
by: V. A. Karlov, et al.
Published: (2020-11-01) -
Efficacy assessment of levetiracetam monotherapy in newly-diagnosed epilepsy in adults using epileptiform activity index
by: V. A. Karlov, et al.
Published: (2020-09-01) -
Is it possible to predict the treatment efficacy in adult patients with focal epilepsy?
by: K. V. Firsov, et al.
Published: (2020-01-01) -
Efficacy and safety of using eslicarbazepine in treating focal epilepsy in clinical practice (based on international Euro-Esli study and personal experience)
by: I. A. Zhidkova, et al.
Published: (2020-11-01) -
A NEW ANTIEPILEPTIC DRUG — ZONEGRAN (ZONISAMIDE) — IN THE TREATMENT OF EPILEPSY (A REVIEW)
by: O. A. Pylaeva, et al.
Published: (2015-07-01)